Cargando…
de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins
Autism spectrum disorders (ASDs) are the most common neurodevelopmental disorders with unidentified etiology. The behavioral manifestations of ASD may be a consequence of genetic and/or environmental pathology in neurodevelopmental processes. In this limited study, we assayed autoantibodies to a pan...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563083/ https://www.ncbi.nlm.nih.gov/pubmed/31035713 http://dx.doi.org/10.3390/bs9050047 |
_version_ | 1783426470146736128 |
---|---|
author | Abou-Donia, Mohamed B. Suliman, Hagir B. Siniscalco, Dario Antonucci, Nicola ElKafrawy, Passent Brahmajothi, Mulugu V. |
author_facet | Abou-Donia, Mohamed B. Suliman, Hagir B. Siniscalco, Dario Antonucci, Nicola ElKafrawy, Passent Brahmajothi, Mulugu V. |
author_sort | Abou-Donia, Mohamed B. |
collection | PubMed |
description | Autism spectrum disorders (ASDs) are the most common neurodevelopmental disorders with unidentified etiology. The behavioral manifestations of ASD may be a consequence of genetic and/or environmental pathology in neurodevelopmental processes. In this limited study, we assayed autoantibodies to a panel of vital neuronal and glial proteins in the sera of 40 subjects (10 children with ASD and their mothers along with 10 healthy controls, age-matched children and their mothers). Serum samples were screened using Western Blot analysis to measure immunoglobulin (IgG) reactivity against a panel of 9 neuronal proteins commonly associated with neuronal degeneration: neurofilament triplet proteins (NFP), tubulin, microtubule-associated proteins (tau), microtubule-associated protein-2 (MAP-2), myelin basic protein (MBP), myelin-associated glycoprotein (MAG), α-synuclein (SNCA) and astrocytes proteins such as glial fibrillary acidic protein (GFAP) and S100B protein. Our data show that the levels of circulating IgG class autoantibodies against the nine proteins were significantly elevated in ASD children. Mothers of ASD children exhibited increased levels of autoantibodies against all panel of tested proteins except for S100B and tubulin compared to age-matched healthy control children and their mothers. Control children and their mothers showed low and insignificant levels of autoantibodies to neuronal and glial proteins. These results strongly support the importance of anti-neuronal and glial protein autoantibodies biomarker in screening for ASD children and further confirm the importance of the involvement of the maternal immune system as an index that should be considered in fetal in utero environmental exposures. More studies are needed using larger cohort to verify these results and understand the importance of the presence of such autoantibodies in children with autism and their mothers, both as biomarkers and their role in the mechanism of action of autism and perhaps in its treatment. |
format | Online Article Text |
id | pubmed-6563083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65630832019-06-17 de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins Abou-Donia, Mohamed B. Suliman, Hagir B. Siniscalco, Dario Antonucci, Nicola ElKafrawy, Passent Brahmajothi, Mulugu V. Behav Sci (Basel) Article Autism spectrum disorders (ASDs) are the most common neurodevelopmental disorders with unidentified etiology. The behavioral manifestations of ASD may be a consequence of genetic and/or environmental pathology in neurodevelopmental processes. In this limited study, we assayed autoantibodies to a panel of vital neuronal and glial proteins in the sera of 40 subjects (10 children with ASD and their mothers along with 10 healthy controls, age-matched children and their mothers). Serum samples were screened using Western Blot analysis to measure immunoglobulin (IgG) reactivity against a panel of 9 neuronal proteins commonly associated with neuronal degeneration: neurofilament triplet proteins (NFP), tubulin, microtubule-associated proteins (tau), microtubule-associated protein-2 (MAP-2), myelin basic protein (MBP), myelin-associated glycoprotein (MAG), α-synuclein (SNCA) and astrocytes proteins such as glial fibrillary acidic protein (GFAP) and S100B protein. Our data show that the levels of circulating IgG class autoantibodies against the nine proteins were significantly elevated in ASD children. Mothers of ASD children exhibited increased levels of autoantibodies against all panel of tested proteins except for S100B and tubulin compared to age-matched healthy control children and their mothers. Control children and their mothers showed low and insignificant levels of autoantibodies to neuronal and glial proteins. These results strongly support the importance of anti-neuronal and glial protein autoantibodies biomarker in screening for ASD children and further confirm the importance of the involvement of the maternal immune system as an index that should be considered in fetal in utero environmental exposures. More studies are needed using larger cohort to verify these results and understand the importance of the presence of such autoantibodies in children with autism and their mothers, both as biomarkers and their role in the mechanism of action of autism and perhaps in its treatment. MDPI 2019-04-29 /pmc/articles/PMC6563083/ /pubmed/31035713 http://dx.doi.org/10.3390/bs9050047 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Abou-Donia, Mohamed B. Suliman, Hagir B. Siniscalco, Dario Antonucci, Nicola ElKafrawy, Passent Brahmajothi, Mulugu V. de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins |
title | de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins |
title_full | de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins |
title_fullStr | de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins |
title_full_unstemmed | de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins |
title_short | de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins |
title_sort | de novo blood biomarkers in autism: autoantibodies against neuronal and glial proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563083/ https://www.ncbi.nlm.nih.gov/pubmed/31035713 http://dx.doi.org/10.3390/bs9050047 |
work_keys_str_mv | AT aboudoniamohamedb denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins AT sulimanhagirb denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins AT siniscalcodario denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins AT antonuccinicola denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins AT elkafrawypassent denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins AT brahmajothimuluguv denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins |